Oncology & Cancer

Multicancer early detection feasible for outpatients

A blood-based multicancer early detection (MCED) test using cell-free DNA (cfDNA) is feasible for outpatients and has a positive predictive value of about 40 percent, according to a study presented at the annual meeting of ...

Neuroscience

New blood test for ALS promises rapid diagnosis

Patients with ALS, one of the most serious neurological diseases known, have been hampered by the time it takes to receive an accurate diagnosis. The period between the onset of symptoms and diagnosis averages over a year, ...

Oncology & Cancer

New test could speed up the diagnosis of womb cancer

A new PCR test that identifies women with womb cancer from a sample taken from the cervix or vagina has been developed by researchers from UCL and the University of Innsbruck.

Medical research

Lung cancer: When radiotherapy fails

Lung cancer is the most common cancer in the world, with 2.2 million new cases and around 1.8 million deaths in 2020 alone. Although knowledge about the disease has improved considerably, and new therapeutic strategies can ...

page 6 from 34